Inovio Pharmaceuticals (INO) Amortizatization of Intangibles (2016 - 2025)

Inovio Pharmaceuticals (INO) has disclosed Amortizatization of Intangibles for 16 consecutive years, with $53266.0 as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 92.07% to $53266.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2399.0 through Dec 2025, down 99.86% year-over-year, with the annual reading at $2399.0 for FY2025, 99.86% down from the prior year.
  • Amortizatization of Intangibles hit $53266.0 in Q4 2025 for Inovio Pharmaceuticals, up from -$63870.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q4 2021 to a low of -$359080.0 in Q2 2025.
  • Historically, Amortizatization of Intangibles has averaged $274348.6 across 5 years, with a median of $130000.0 in 2021.
  • Biggest five-year swings in Amortizatization of Intangibles: surged 1120.0% in 2021 and later plummeted 2815.79% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $1.7 million in 2021, then tumbled by 80.46% to $326597.0 in 2022, then tumbled by 80.61% to $63334.0 in 2023, then soared by 960.47% to $671640.0 in 2024, then plummeted by 92.07% to $53266.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for INO at $53266.0 in Q4 2025, -$63870.0 in Q3 2025, and -$359080.0 in Q2 2025.